A Review On Insulin Pump Therapy

Insulin pump therapy, clinically known as Continuous Subcutaneous Insulin Infusion (CSII), represents a sophisticated shift in diabetes management from conventional multiple daily injections (MDI). By delivering a continuous supply of rapid-acting insulin through a subcutaneous cannula, the therapy more closely mimics the physiological insulin secretion of a healthy pancreas. The current data indicate there are over 1 million people with diabetes on insulin pump therapy worldwide3 and 350,000 to 515,000 in the United States4. Insulin pump therapy offers increased lifestyle flexibility and improved glucose management. The goal of this paper is to outline the topics that should be covered by diabetes care and education specialists when teaching people with diabetes (PWD) and their families or significant others. It focuses on insulin pump therapy and the importance of maintaining a high level of expertise in this subspecialty of diabetes education if choosing to include pump and sensor training in the individual specialist's practice.